{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4OjI06UKDA","founded_year":2000,"lastupdate":"2022-11-29T00:00:00.000Z","update_date":"2022-11-29T00:00:00.000Z","lastModified":"Apr 17, 2019","confidence_score":57,"active":1,"confidence_score_reason":"funding stage, product stage, sector, founding month, business model, video or image, funding rounds, markets, not claimed","urlname":"izun-pharmaceuticals1","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"description_edited":0,"tag_line_edited":0,"phone":"+972722458950","registrar":"","biverification":"Yamila Silbert","recentupdates":[{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:23:56.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:24:19.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:23:56.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:23:56.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:23:56.000000","last_name":"Perlov","first_name":"Maor"},{"email":"mbadyaeva@gmail.com","source":"Automatic","datetime":"2023-03-26 08:01:44.000000","last_name":"Badyaeva","first_name":"Marina"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:25:45.000000","last_name":"Perlov","first_name":"Maor"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-04-17 05:25:18.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:36:07.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:10:29.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:18.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:11.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:17.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:19.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 21:38:16.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:17.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:07:53.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:18.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2019-04-03 22:25:20.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-04-17 05:21:18.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-04-17 05:25:11.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-04-17 05:25:11.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-04-17 05:21:41.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-29 07:25:46.000000","last_name":"Perlov","first_name":"Maor"}],"sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGr0IIIDA","fullname":"Yamila Silbert"},"biverifydate":"2019-04-17T00:00:00.000Z","crunchbaseid":"","lastupdator":"Maor Perlov","lastupdator_email":"maor.perlov@sncentral.org","creator":"Yanina Wainscheinker","creator_email":"yanina.wain@gmail.com","createdate":"2019-04-03T00:00:00.000Z","lastupdatedate":"2022-11-29","hide_reason":null,"hide_reason_data":null,"logokey":"$G4HIAoMO3Isv7e48LMQqWv4D453haK0IiivBuxjQyfQb1MTyjBLBQe","name":"Izun Pharmaceuticals","israeliacquisitions":0,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":[""],"country":"United States","inisraelsince":"10/2000","inisraelsincemonth":"10","isisraeli":0,"marketcapital":null,"marketcapitaldate":null,"oneliner":"Pharmaceuticals","website":"https://www.izunpharma.com/","employees":"1-10","employees_exact":6,"employees_overall":"1-500","employees_overall_exact":251,"sociallinks":{"twitter":"https://twitter.com/Izunpharma","youtube":"","facebook":"","linkedin":"","instagram":""},"social":["https://twitter.com/Izunpharma"],"flattenedsociallinks":"https://twitter.com/Izunpharma","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Izun Pharmaceuticals Corporation focuses on natural solutions in the area of periodontal inflammation. Izuns products are both efficacious and safe, providing novel solutions with the potential to capitalize on multi-billion-dollar market opportunities. \r\n\r\nIzun Pharma Ltd is a wholly-owned Jerusalem-based R&D subsidiary. A proprietary, botanically-based platform technology was developed which helps treat a wide range of inflammatory diseases, while simultaneously accelerating the bodys natural tissue repair processes. ","founded":"2000","team":[{"name":"William  Levine","email":"wzlevine@izunpharma.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGyitYIDA","bounced":false,"claimed":0,"founder":1,"urlname":"william-levine","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg6KyinwsM","position":"Founder & Chief Scientific Officer","last_name":"Levine","claimtoken":"WLaZecmEAxzuC39bqYtqj8QnvYx0MazKfnYu91qZnhAsdHL5FuzC3E","first_name":"William ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/william-levine-91507610/","unsubscribed":false,"is_activeuser":0,"additionalemail":"wzlevin@izunpharma.com","claimedemaildate":"2022-11-29 07:15:17.000000","initials":"WL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"portfolio":[],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":[{"id":"31710139-45d4-4e34-a593-4a84796c6f01","city":"Jerusalem","type":["R&D"],"address":"Kiryat HaMada 5, Jerusalem, Israel","placeid":null,"notactive":0,"openeddate":"2000-10-01","registrarid":"513019307","firstrdcenter":0,"registrarname":"Izun Pharma Ltd"}],"officesabroad":[{"id":"SRUwMGcBNi7pVbCwpFjEGzI0vwmo2OqPo8NzPaKKAlWsAxDgB3kri3","city":"New York","address":"1 Rockefeller Plaza, New York, NY 10020, USA","country":"United States","placeid":null}]},"headquarter_address":"1 Rockefeller Plaza, New York, NY 10020, USA","news":[{"id":"850e9640-7fa4-48bf-839b-a23c8bb2afbb","date":"Oct 11, 2017","link":"https://www.businesswire.com/news/home/20171011005127/en/Izun-Pharmaceuticals-Announces-Positive-Results-Phase-2","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"FVGFZPJ3kQtCEjBdSzPPV1A9k58IwMmCBzwGXo2rzvX3R5xDuQDbbT","news_summary":"Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[],"techcommunityinvolvement":null,"tags":["tissue-regeneration","inflammatory-diseases","topical-treatment","pharmaceuticals"],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"1-500","fundingtype":"Multinational","parsedName":"Izun Pharmaceuticals","logourl":"https://storage.googleapis.com/clean-finder-353810/$G4HIAoMO3Isv7e48LMQqWv4D453haK0IiivBuxjQyfQb1MTyjBLBQe","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$G4HIAoMO3Isv7e48LMQqWv4D453haK0IiivBuxjQyfQb1MTyjBLBQe","teamMembersNumber":1,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}